Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, William E. Carson, Rachel M. Layman et al.|Cancer Immunology Immunotherapy|2017Cited by 72
Neoadjuvant Dual HER2-Targeted Therapy With Lapatinib and Trastuzumab Improves Pathologic Complete Response in Patients With Early Stage HER2-Positive Breast Cancer: A Meta-Analysis of Randomized Prospective Clinical TrialsMellissa Hicks, Robert Wesolowski, Erin Macrae et al.|The Oncologist|2015Cited by 48
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G. Stover, Maryam B. Lustberg, Raquel E. Reinbolt et al.|JCO Precision Oncology|2019Cited by 18
Treatment-Related Mortality With Everolimus in Cancer PatientsRobert Wesolowski, Erin Macrae, Mahmoud Abdel‐Rasoul et al.|The Oncologist|2014Cited by 17
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth Adams, Daniel G. Stover, Sarah Asad et al.|BMC Cancer|2020Cited by 16